Impact of Pharmacogenomics on Transplant Outcomes: Review of Recent Literature

Key Points

• Transplant outcomes are significantly affected by pharmacogenomics, influencing medication effectiveness.
• Key evidence suggests genetic variants play a critical role in drug metabolism and response among transplant patients.
• Observational analysis across various studies reveals the relationship between biomarkers and transplant success rates.
• The findings support the potential for personalized medicine approaches, indicating better patient outcomes through tailored therapies.